Drug Shortage Report for MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE
Report ID | 47356 |
Drug Identification Number | 02461412 |
Brand name | MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE |
Common or Proper name | EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | EFAVIRENZ TENOFOVIR DISOPROXIL FUMARATE EMTRICITABINE |
Strength(s) | 600MG 300MG 200MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30 BT |
ATC code | J05AR |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2019-06-11 |
Actual start date | |
Estimated end date | 2019-06-21 |
Actual end date | 2019-06-18 |
Shortage status | Resolved |
Updated date | 2019-06-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v44 | 2019-03-28 | English | Compare |
v43 | 2019-03-20 | French | Compare |
v42 | 2019-03-20 | English | Compare |
v41 | 2019-03-05 | French | Compare |
v40 | 2019-03-05 | English | Compare |
v39 | 2019-02-21 | French | Compare |
v38 | 2019-02-21 | English | Compare |
v37 | 2019-01-08 | French | Compare |
v36 | 2019-01-08 | English | Compare |
v35 | 2019-01-02 | French | Compare |
v34 | 2019-01-02 | English | Compare |
v33 | 2018-12-05 | French | Compare |
v32 | 2018-12-05 | English | Compare |
v31 | 2018-11-30 | French | Compare |
v30 | 2018-11-30 | English | Compare |
v29 | 2018-11-20 | French | Compare |
v28 | 2018-11-20 | English | Compare |
v27 | 2018-11-13 | French | Compare |
v26 | 2018-11-13 | English | Compare |
v25 | 2018-11-13 | French | Compare |